Tumour necrosis factor (TNF) inhibitors are more likely discontinued due to ineffectiveness in patients aged 16-24 years than in those aged 45-54 years. However, patients aged ≥ 75 years have an ...
Patients with psoriasis who received biologic treatments were at significantly lower risk of developing psoriatic arthritis, with women representing a potentially at-risk group. Biologic treatments ...
CORRECTED April 15, 2024 // An earlier version of this article stated incorrect percentages of patients who never received any biologics during the study's 3-year period but improved rapidly or ...
The topic of high prescription drug prices is now the dominant policy issue on Capitol Hill. The new Congress has held a half-dozen hearings on the topic. But one issue that is at the heart of high ...
Psoriasis treatment has come a long way in the last 30 years. There’s no cure, but medication can help you gain control of your symptoms. If your current treatment doesn’t help enough, the doctor ...
The Window of Opportunity: Why Early Biologic Use Matters for Patients With Hidradenitis Suppurativa
Panelists discuss the critical importance of early biologic therapy initiation in hidradenitis suppurativa to prevent irreversible tissue damage, reduce disease burden, and overcome socioeconomic and ...
It may take some trial and error to find the biologic drug that works best for your rheumatoid arthritis (RA), but there's a good reason to keep at it. Most folks ...
They were the drugs that were supposed to save the U.S. tens of billions of dollars. Called "biosimilars," they are near-copies of complex and expensive biologic drugs to treat cancer, rare diseases ...
In patients undergoing aortic-valve or mitral-valve replacement, either a mechanical or biologic prosthesis is used. Biologic prostheses have been increasingly favored despite limited evidence ...
What you should know about the safety and side effects of biologic drugs for psoriasis and arthritis
Biologic drugs that treat various autoimmune disorders have seen substantial increases in prescriptions over the last 20 years. The drugs are effective in treating rheumatoid arthritis, psoriasis and ...
TORONTO and HAIFA, Israel, April 10, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) is pleased to provide a business update and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback